| |
| |
|
| Insider
Information: |
Trizzino John |
| Relationship: |
President and COO |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,972 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,056 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
27,972 |
|
|
| Total
Value |
$10,056 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President and COO |
2024-03-10 |
27,972 |
2011-08-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-03-05 |
4 |
OE |
$5.95 |
$50,148 |
D/D |
3,404 |
670 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-02-05 |
4 |
OE |
$5.95 |
$50,160 |
D/D |
3,406 |
671 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-05 |
4 |
OE |
$5.95 |
$50,160 |
D/D |
3,406 |
671 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-02-05 |
4 |
D |
$290.18 |
$52,813 |
D/D |
(182) |
481 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-01-05 |
4/A |
D |
$116.24 |
$59,399 |
D/D |
(511) |
866 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CMO and CBO |
• – – |
2021-01-07 |
4 |
AS |
$124.17 |
$62,830 |
D/D |
(506) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-02-09 |
4 |
AS |
$324.50 |
$62,953 |
D/D |
(194) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CMO and CBO |
• – – |
2021-01-05 |
4 |
D |
$116.24 |
$67,884 |
D/D |
(584) |
793 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-06-25 |
4 |
D |
$189.79 |
$76,485 |
D/D |
(403) |
718 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2024-03-07 |
4 |
D |
$5.61 |
$78,288 |
D/D |
(13,955) |
25,590 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, CBO and CFO |
• – – |
2018-05-14 |
4 |
B |
$1.64 |
$81,995 |
D/D |
50,000 |
138,965 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Commercial Operations |
• – – |
2016-09-22 |
4 |
B |
$2.17 |
$99,820 |
D/D |
46,000 |
85,564 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-04-05 |
4 |
OE |
$5.95 |
$115,771 |
D/D |
3,404 |
670 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-12-14 |
4 |
D |
$168.43 |
$130,196 |
D/D |
(773) |
3,373 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-13 |
4 |
OE |
$19.08 |
$143,081 |
D/D |
7,499 |
8,217 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-14 |
4 |
OE |
$19.08 |
$143,081 |
D/D |
7,499 |
8,217 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-20 |
4 |
OE |
$19.08 |
$143,100 |
D/D |
7,500 |
8,218 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-21 |
4 |
OE |
$19.08 |
$143,100 |
D/D |
7,500 |
8,218 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-27 |
4 |
OE |
$19.08 |
$143,119 |
D/D |
7,501 |
10,047 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-28 |
4 |
OE |
$19.08 |
$143,119 |
D/D |
7,501 |
10,047 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
OE |
$5.95 |
$176,120 |
D/D |
29,600 |
53,008 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-28 |
4 |
D |
$111.18 |
$233,812 |
D/D |
(2,103) |
50,658 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CBO and CFO |
• – – |
2020-09-30 |
4 |
AS |
$107.60 |
$248,002 |
D/D |
(2,250) |
5,087 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CMO and CBO |
• – – |
2021-01-05 |
4 |
OE |
$5.95 |
$256,243 |
D/D |
13,756 |
1,436 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-26 |
4 |
D |
$248.16 |
$424,105 |
D/D |
(1,709) |
2,546 |
0 |
- |
|
91 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
